Global Biopsy Devices Market
Description
MARKET SCOPE:
The global Biopsy Devices market is projected to grow significantly, registering a CAGR of 6.7% during the forecast period (2023 – 2032).
The biopsy devices market refers to the healthcare sector involved in the manufacturing, distribution, and utilization of devices used for obtaining tissue or cell samples from the human body for diagnostic purposes. Biopsy is a medical procedure performed to extract a small piece of tissue or cells from a specific area in the body, which is then examined under a microscope to diagnose various medical conditions, including cancer and other diseases. Biopsy devices play a crucial role in this process by providing tools for healthcare professionals to safely and accurately collect tissue samples. These devices can vary in design and functionality based on the type of biopsy procedure, such as needle biopsies, core biopsies, or surgical biopsies. The biopsy devices market encompasses a range of products, including biopsy needles, biopsy forceps, biopsy guns, and guidance systems used in minimally invasive procedures. The market's growth is influenced by factors such as increasing prevalence of cancer, advancements in biopsy technologies, and a rising emphasis on early and accurate diagnosis for improved patient outcomes.
MARKET OVERVIEW:
Driver: The increasing incidence of cancer and other chronic diseases worldwide is driving the market growth.
One of the key drivers for the biopsy devices market is the increasing incidence of cancer and other chronic diseases. As the global population ages and lifestyles change, the prevalence of cancer continues to rise. Biopsy devices play a critical role in the early detection and accurate diagnosis of various types of cancers, driving the demand for these devices. The emphasis on early diagnosis for better treatment outcomes is a significant factor fueling the growth of the biopsy devices market. Additionally, advancements in biopsy technologies, such as minimally invasive procedures and imaging-guided biopsies, contribute to the market's expansion.
Opportunities: The continuous technological advancements are expected to pave the way for market growth in the upcoming years.
An important opportunity for the biopsy devices market lies in the continuous technological advancements and innovation in the field. Ongoing research and development efforts are leading to the introduction of more efficient and precise biopsy devices. Innovations in imaging technologies, robotics, and molecular diagnostics enhance the accuracy and reliability of biopsy procedures. The expansion of applications beyond oncology, such as biopsy devices used in autoimmune diseases or infectious diseases, presents a broader scope for market growth. Moreover, the increasing awareness about the importance of regular screenings and early diagnosis creates opportunities for the adoption of biopsy devices in preventive healthcare.
COVID IMPACT:
The COVID-19 pandemic has had a mixed impact on the biopsy devices market. On one hand, there have been disruptions due to the redirection of healthcare resources towards managing the pandemic. Elective procedures, including certain types of biopsies, were postponed or canceled during periods of high infection rates. On the other hand, the pandemic highlighted the importance of diagnostic tools, including biopsies, in identifying and managing various health conditions. The backlog of postponed procedures is expected to lead to a surge in demand for biopsy devices in the post-pandemic period. Additionally, the focus on telemedicine and remote patient monitoring during the pandemic has prompted the exploration of innovative solutions in the biopsy devices market, such as remote biopsy guidance systems.
In summary, while the pandemic has presented challenges, it has also underscored the crucial role of biopsy devices in healthcare, and the market is poised to rebound with increased emphasis on early diagnosis and advancements in technology.
SEGMENTATION ANALYSIS:
The application sector is anticipated to grow significantly during the forecast period
Gynecological, breast, prostate, lung, and kidney biopsies are all examples of biopsies. Due to the rising incidence of breast cancer and increased public awareness of the condition, breast biopsy accounts for the greatest market share. A lung biopsy is a process where samples of lung tissue are extracted (during surgery or with a specific biopsy needle) to check for the presence of lung illness or cancer. Either a closed procedure or an open method can be used to take a lung biopsy. While in a kidney biopsy, a small portion of kidney tissue is removed so that it may be studied under a microscope for indications of injury or illness. Devices are categorized into diagnostic, imaging centers, and hospitals according to the end-user biopsy. The biopsy devices market is poised for significant growth, with the application sector expected to experience notable expansion during the forecast period. Several factors contribute to this anticipated growth, highlighting the increasing importance of biopsy devices in medical diagnostics and healthcare.
One key driver is the rising incidence of cancer and other diseases that require precise diagnostic procedures. Biopsy devices play a crucial role in obtaining tissue samples for accurate diagnosis and staging of various medical conditions. As the global burden of cancer continues to increase, the demand for biopsy devices across different medical applications is expected to grow significantly. Advancements in technology, such as the development of minimally invasive biopsy procedures and imaging-guided biopsy techniques, contribute to the expanded applications of biopsy devices. These innovations enhance the accuracy and efficiency of tissue sampling, making biopsies more accessible and acceptable for patients.
Moreover, the aging population globally is leading to a higher prevalence of diseases, including cancer and other conditions that necessitate diagnostic biopsies. This demographic trend contributes to the growing demand for biopsy devices in various medical specialties. The emphasis on personalized medicine and targeted therapies also drives the need for precise and reliable diagnostic information obtained through biopsy procedures. Biopsy devices, equipped with advanced features and capabilities, become essential tools in tailoring treatment plans to individual patient profiles. The forecasted growth in the application sector of the biopsy devices market indicates a broader trend toward advancing diagnostic capabilities and improving patient outcomes. As technology continues to evolve and healthcare practices become more specialized, biopsy devices are expected to play a central role in the diagnosis and treatment decision-making process.
REGIONAL ANALYSIS:
The North American region is set to witness significant growth during the forecast period.
North America dominates the largest market for biopsy devices market. More than 39% of market revenues came from North America. Due to the existing regional companies, the area will probably continue to hold a sizable market share from 2024 To 2032. Additionally, it is predicted that the biopsy device market in this region will profit from a quickly growing demand for disposable devices and strong market penetration rates of cutting-edge technical gadgets. Also, in the North America region, Point-of-care diagnostic tools for early and secure illness detection are now widely accepted as a result of the rising occurrence of infectious diseases. Due to its well-established healthcare infrastructure and sophisticated insurance and co-payment systems, the North American area dominates the industry.
COMPETITIVE ANALYSIS
The global biopsy devices market is reasonably competitive with mergers, acquisitions, and product launches. See some of the major key players in the market.
Olympus Corporation
On February 24, 2023, Olympus completed the acquisition of Taewoong Medical Co., Ltd., a Korean company specializing in gastrointestinal stents. This strategic move aligns with Olympus's commitment to enhancing people's lives by fostering health, safety, and overall well-being.
Olympus Corporation
On April 23, 2020, Olympus Corporation introduced the EVIS X1, its cutting-edge endoscopy system designed to enhance outcomes for conditions affecting the stomach, colon, and bronchial diseases. This system aims to equip every endoscopist with innovative and reliable tools to improve patient care.
Argon Medical Devices, Inc.
B. Braun Melsungen AG
Becton Dickinson and Company
Boston Scientific Corporation
Cardinal Health
Cook Medical, Inc.
Danaher Corporation
Fujifilm Holdings Corp.
Hologic, Inc.
Medtronic plc.
SCOPE OF THE REPORT
By Product
Core Needle Biopsy
Aspiration Biopsy
Vacuum Assisted Biopsy
Biopsy Forceps
Localization Wires
By Technology
MRI Guided Biopsy
Stereotactic Guided Biopsy
Ultrasound Guided Biopsy
CT scan
By Application
Breast biopsy
Lung biopsy
Prostate biopsy
Kidney biopsy
Gynecological biopsy
By End - User
Diagnostic
Imaging Centers
Hospitals
By Region
North America (the United States & Canada)
Europe (Germany, UK, France, Spain, Italy, and the Rest of Europe)
Asia Pacific (China, Japan, India, and Rest of Asia Pacific)
Rest of the World (the Middle East & Africa, and Latin America)
KEY REASONS TO PURCHASE THIS REPORT
It provides a technological development map over time to understand the industry’s growth rate and indicates how the Biopsy Devices market is evolving.
The report offers a dynamic method to various factors that drive or restrain the growth of the market and specifies which Biopsy Devices submarket will be the main driver of the overall market from 2024 to 2032.
It renders a definite analysis of changing competitive dynamics and stipulates the leading players and what are their prospects over the forecast period.
It builds a nine-year estimate based on how the market is predicted to grow and shows what will market shares of the global region change by 2032 and which country will lead the market in 2032.
The global Biopsy Devices market is projected to grow significantly, registering a CAGR of 6.7% during the forecast period (2023 – 2032).
The biopsy devices market refers to the healthcare sector involved in the manufacturing, distribution, and utilization of devices used for obtaining tissue or cell samples from the human body for diagnostic purposes. Biopsy is a medical procedure performed to extract a small piece of tissue or cells from a specific area in the body, which is then examined under a microscope to diagnose various medical conditions, including cancer and other diseases. Biopsy devices play a crucial role in this process by providing tools for healthcare professionals to safely and accurately collect tissue samples. These devices can vary in design and functionality based on the type of biopsy procedure, such as needle biopsies, core biopsies, or surgical biopsies. The biopsy devices market encompasses a range of products, including biopsy needles, biopsy forceps, biopsy guns, and guidance systems used in minimally invasive procedures. The market's growth is influenced by factors such as increasing prevalence of cancer, advancements in biopsy technologies, and a rising emphasis on early and accurate diagnosis for improved patient outcomes.
MARKET OVERVIEW:
Driver: The increasing incidence of cancer and other chronic diseases worldwide is driving the market growth.
One of the key drivers for the biopsy devices market is the increasing incidence of cancer and other chronic diseases. As the global population ages and lifestyles change, the prevalence of cancer continues to rise. Biopsy devices play a critical role in the early detection and accurate diagnosis of various types of cancers, driving the demand for these devices. The emphasis on early diagnosis for better treatment outcomes is a significant factor fueling the growth of the biopsy devices market. Additionally, advancements in biopsy technologies, such as minimally invasive procedures and imaging-guided biopsies, contribute to the market's expansion.
Opportunities: The continuous technological advancements are expected to pave the way for market growth in the upcoming years.
An important opportunity for the biopsy devices market lies in the continuous technological advancements and innovation in the field. Ongoing research and development efforts are leading to the introduction of more efficient and precise biopsy devices. Innovations in imaging technologies, robotics, and molecular diagnostics enhance the accuracy and reliability of biopsy procedures. The expansion of applications beyond oncology, such as biopsy devices used in autoimmune diseases or infectious diseases, presents a broader scope for market growth. Moreover, the increasing awareness about the importance of regular screenings and early diagnosis creates opportunities for the adoption of biopsy devices in preventive healthcare.
COVID IMPACT:
The COVID-19 pandemic has had a mixed impact on the biopsy devices market. On one hand, there have been disruptions due to the redirection of healthcare resources towards managing the pandemic. Elective procedures, including certain types of biopsies, were postponed or canceled during periods of high infection rates. On the other hand, the pandemic highlighted the importance of diagnostic tools, including biopsies, in identifying and managing various health conditions. The backlog of postponed procedures is expected to lead to a surge in demand for biopsy devices in the post-pandemic period. Additionally, the focus on telemedicine and remote patient monitoring during the pandemic has prompted the exploration of innovative solutions in the biopsy devices market, such as remote biopsy guidance systems.
In summary, while the pandemic has presented challenges, it has also underscored the crucial role of biopsy devices in healthcare, and the market is poised to rebound with increased emphasis on early diagnosis and advancements in technology.
SEGMENTATION ANALYSIS:
The application sector is anticipated to grow significantly during the forecast period
Gynecological, breast, prostate, lung, and kidney biopsies are all examples of biopsies. Due to the rising incidence of breast cancer and increased public awareness of the condition, breast biopsy accounts for the greatest market share. A lung biopsy is a process where samples of lung tissue are extracted (during surgery or with a specific biopsy needle) to check for the presence of lung illness or cancer. Either a closed procedure or an open method can be used to take a lung biopsy. While in a kidney biopsy, a small portion of kidney tissue is removed so that it may be studied under a microscope for indications of injury or illness. Devices are categorized into diagnostic, imaging centers, and hospitals according to the end-user biopsy. The biopsy devices market is poised for significant growth, with the application sector expected to experience notable expansion during the forecast period. Several factors contribute to this anticipated growth, highlighting the increasing importance of biopsy devices in medical diagnostics and healthcare.
One key driver is the rising incidence of cancer and other diseases that require precise diagnostic procedures. Biopsy devices play a crucial role in obtaining tissue samples for accurate diagnosis and staging of various medical conditions. As the global burden of cancer continues to increase, the demand for biopsy devices across different medical applications is expected to grow significantly. Advancements in technology, such as the development of minimally invasive biopsy procedures and imaging-guided biopsy techniques, contribute to the expanded applications of biopsy devices. These innovations enhance the accuracy and efficiency of tissue sampling, making biopsies more accessible and acceptable for patients.
Moreover, the aging population globally is leading to a higher prevalence of diseases, including cancer and other conditions that necessitate diagnostic biopsies. This demographic trend contributes to the growing demand for biopsy devices in various medical specialties. The emphasis on personalized medicine and targeted therapies also drives the need for precise and reliable diagnostic information obtained through biopsy procedures. Biopsy devices, equipped with advanced features and capabilities, become essential tools in tailoring treatment plans to individual patient profiles. The forecasted growth in the application sector of the biopsy devices market indicates a broader trend toward advancing diagnostic capabilities and improving patient outcomes. As technology continues to evolve and healthcare practices become more specialized, biopsy devices are expected to play a central role in the diagnosis and treatment decision-making process.
REGIONAL ANALYSIS:
The North American region is set to witness significant growth during the forecast period.
North America dominates the largest market for biopsy devices market. More than 39% of market revenues came from North America. Due to the existing regional companies, the area will probably continue to hold a sizable market share from 2024 To 2032. Additionally, it is predicted that the biopsy device market in this region will profit from a quickly growing demand for disposable devices and strong market penetration rates of cutting-edge technical gadgets. Also, in the North America region, Point-of-care diagnostic tools for early and secure illness detection are now widely accepted as a result of the rising occurrence of infectious diseases. Due to its well-established healthcare infrastructure and sophisticated insurance and co-payment systems, the North American area dominates the industry.
COMPETITIVE ANALYSIS
The global biopsy devices market is reasonably competitive with mergers, acquisitions, and product launches. See some of the major key players in the market.
Olympus Corporation
On February 24, 2023, Olympus completed the acquisition of Taewoong Medical Co., Ltd., a Korean company specializing in gastrointestinal stents. This strategic move aligns with Olympus's commitment to enhancing people's lives by fostering health, safety, and overall well-being.
Olympus Corporation
On April 23, 2020, Olympus Corporation introduced the EVIS X1, its cutting-edge endoscopy system designed to enhance outcomes for conditions affecting the stomach, colon, and bronchial diseases. This system aims to equip every endoscopist with innovative and reliable tools to improve patient care.
Argon Medical Devices, Inc.
B. Braun Melsungen AG
Becton Dickinson and Company
Boston Scientific Corporation
Cardinal Health
Cook Medical, Inc.
Danaher Corporation
Fujifilm Holdings Corp.
Hologic, Inc.
Medtronic plc.
SCOPE OF THE REPORT
By Product
Core Needle Biopsy
Aspiration Biopsy
Vacuum Assisted Biopsy
Biopsy Forceps
Localization Wires
By Technology
MRI Guided Biopsy
Stereotactic Guided Biopsy
Ultrasound Guided Biopsy
CT scan
By Application
Breast biopsy
Lung biopsy
Prostate biopsy
Kidney biopsy
Gynecological biopsy
By End - User
Diagnostic
Imaging Centers
Hospitals
By Region
North America (the United States & Canada)
Europe (Germany, UK, France, Spain, Italy, and the Rest of Europe)
Asia Pacific (China, Japan, India, and Rest of Asia Pacific)
Rest of the World (the Middle East & Africa, and Latin America)
KEY REASONS TO PURCHASE THIS REPORT
It provides a technological development map over time to understand the industry’s growth rate and indicates how the Biopsy Devices market is evolving.
The report offers a dynamic method to various factors that drive or restrain the growth of the market and specifies which Biopsy Devices submarket will be the main driver of the overall market from 2024 to 2032.
It renders a definite analysis of changing competitive dynamics and stipulates the leading players and what are their prospects over the forecast period.
It builds a nine-year estimate based on how the market is predicted to grow and shows what will market shares of the global region change by 2032 and which country will lead the market in 2032.
Table of Contents
191 Pages
- 1. Executive Summary
- 1.1. Market Snapshot
- 1.2. Regional Analysis
- 1.3. Segment Analysis
- 2. Overview And Scope
- 2.1. Market Vision
- 2.1.1. Market Definition
- 2.2. Market Segmentation
- 3. Global Biopsy Devices Market Overview By Region: 2019 Vs 2023 Vs 2032
- 3.1. Global Biopsy Devices Market Size By Region (2019-2023) (Usd Million)
- 3.1.1. North America Biopsy Devices Market Size By Country (2019-2023) (Usd Million)
- 3.1.2. Europe Biopsy Devices Market Size By Country (2019-2023) (Usd Million)
- 3.1.3. Asia Pacific America Biopsy Devices Market Size By Country (2019-2023) (Usd Million)
- 3.1.4. Rest Of The World Biopsy Devices Market Size By Country (2019-2023) (Usd Million)
- 3.2. Global Biopsy Devices Market Size By Region (2024-2032) (Usd Million)
- 3.2.1. North America Biopsy Devices Market Size By Country (2024-2032) (Usd Million)
- 3.2.2. Europe Biopsy Devices Market Size By Country (2024-2032) (Usd Million)
- 3.2.3. Asia Pacific Biopsy Devices Market Size By Country (2024-2032) (Usd Million)
- 3.2.4. Rest Of The World Biopsy Devices Market Size By Country (2024-2032) (Usd Million)
- 4. Global Biopsy Devices Market Dynamics
- 4.1. Market Overview
- 4.1.1. Market Drivers
- 4.1.2. Market Restraints/ Challenges Analysis
- 4.1.3. Market Opportunities
- 4.2. Pestle Analysis
- 4.3. Porter’s Five Forces Model
- 4.3.1. Bargaining Power Of Suppliers
- 4.3.2. Bargaining Power Of Buyers
- 4.3.3. The Threat Of New Entrants
- 4.3.4. Threat Of Substitutes
- 4.3.5. Intensity Of Rivalry
- 4.4. Value Chain Analysis/Supply Chain Analysis
- 4.5. Covid-19 Impact Analysis On Global Biopsy Devices Market
- ** In – Depth Qualitative Analysis Will Be Provided In The Final Report Subject To Market
- 5. Global Biopsy Devices Market, By Product
- 5.1. Overview
- 5.2. Global Biopsy Devices Market Size By Product (2019 - 2032) (Usd Million)
- 5.3. Key Findings For Biopsy Devices Market - By Product
- 5.3.1. Core Needle Biopsy
- 5.3.2. Aspiration Biopsy
- 5.3.3. Vacuum Assisted Biopsy
- 5.3.4. Biopsy Forceps
- 5.3.5. Localization Wires
- 6. Global Biopsy Devices Market, By Technology
- 6.1. Overview
- 6.2. Key Findings For Biopsy Devices Market - By Technology
- 6.2.1. Mri Guided Biopsy
- 6.2.2. Stereotactic Guided Biopsy
- 6.2.3. Ultrasound Guided Biopsy
- 6.2.4. Ct Scan
- 7. Global Biopsy Devices Market, By Application
- 7.1. Overview
- 7.2. Key Findings For Biopsy Devices Market - By Application
- 7.2.1. Breast Biopsy
- 7.2.2. Lung Biopsy
- 7.2.3. Prostate Biopsy
- 7.2.4. Kidney Biopsy
- 7.2.5. Gynecological Biopsy
- 8. Global Biopsy Devices Market, By End User
- 8.1. Overview
- 8.2. Key Findings For Biopsy Devices Market - By End User
- 8.2.1. Diagnostic
- 8.2.2. Imaging Centers
- 8.2.3. Hospitals
- 9. Global Biopsy Devices Market, By Region
- 9.1. Overview
- 9.2. Key Findings For Biopsy Devices Market- By Region
- 9.3. Global Biopsy Devices Market, By Product
- 9.4. Global Biopsy Devices Market, By Technology
- 9.5. Global Biopsy Devices Market, By Application
- 9.6. Global Biopsy Devices Market, By End User
- 10. Global Biopsy Devices Market- North America
- 10.1. Overview
- 10.2. North America Biopsy Devices Market Size (2019 - 2032) (Usd Million)
- 10.3. North America Biopsy Devices Market, By Product
- 10.4. North America Biopsy Devices Market, By Technology
- 10.5. North America Biopsy Devices Market, By Application
- 10.6. North America Biopsy Devices Market, By End User
- 10.7. North America Biopsy Devices Market Size By Countries
- 10.7.1. United States
- 10.7.2. Canada
- 11. Global Biopsy Devices Market- Europe
- 11.1. Overview
- 11.2. Europe Biopsy Devices Market Size (2019 - 2032) (Usd Million)
- 11.3. Europe Biopsy Devices Market, By Product
- 11.4. Europe Biopsy Devices Market, By Technology
- 11.5. Europe Biopsy Devices Market, By Application
- 11.6. Europe Biopsy Devices Market, By End User
- 11.7. Europe Biopsy Devices Market Size By Countries
- 11.7.1. Germany
- 11.7.2. Uk
- 11.7.3. France
- 11.7.4. Spain
- 11.7.5. Italy
- 11.7.6. Rest Of Europe
- 12. Global Biopsy Devices Market - Asia Pacific
- 12.1. Overview
- 12.2. Asia Pacific Biopsy Devices Market Size (2019 - 2032) (Usd Million)
- 12.3. Asia Pacific Biopsy Devices Market, By Product
- 12.4. Asia Pacific Biopsy Devices Market, By Technology
- 12.5. Asia Pacific Biopsy Devices Market, By Application
- 12.6. Asia Pacific Biopsy Devices Market, By End User
- 12.7. Asia Pacific Biopsy Devices Market Size By Countries
- 12.7.1. China
- 12.7.2. Japan
- 12.7.3. India
- 12.7.4. Rest Of Asia Pacific
- 13. Global Biopsy Devices Market- Rest Of World
- 13.1. Overview
- 13.2. Rest Of World Biopsy Devices Market Size (2019 - 2032) (Usd Million)
- 13.3. Rest Of World Biopsy Devices Market, By Product
- 13.4. Rest Of World Biopsy Devices Market, By Technology
- 13.5. Rest Of World Biopsy Devices Market, By Application
- 13.6. Rest Of World Biopsy Devices Market, By End User
- 13.7. Rest Of World Biopsy Devices Market Size By Region
- 13.7.1. Middle East & Africa
- 13.7.2. Latin America
- 14. Global Biopsy Devices Market- Competitive Landscape
- 14.1. Key Strategies Adopted By The Leading Players
- 14.2. Recent Developments
- 14.2.1. Investments & Expansions
- 14.2.2. New End-user Launches
- 14.2.3. Mergers & Acquisitions
- 14.2.4. Agreements, Joint Ventures, And Partnerships
- 15. Global Biopsy Devices Market- Company Profiles
- 15.1. Argon Medical Devices, Inc.
- 15.1.1. Company Overview
- 15.1.2. Financial Overview
- 15.1.3. Product Offered
- 15.1.4. Key Developments
- 15.2. B. Braun Melsungen Ag
- 15.3. Becton Dickinson And Company
- 15.4. Boston Scientific Corporation
- 15.5. Cardinal Health
- 15.6. Cook Medical, Inc.
- 15.7. Danaher Corporation
- 15.8. Fujifilm Holdings Corp.
- 15.9. Hologic, Inc.
- 15.10. Medtronic Plc.
- 15.11. Olympus Corporation
- 16. Our Research Methodology
- 16.1. Data Triangulation
- 16.2. Data Sources
- 16.2.1. Secondary Sources
- 16.2.2. Primary Sources
- 16.3. Assumptions/ Limitations For The Study
- 16.4. Research & Forecasting Methodology
- 17. Appendix
- 17.1. Disclaimer
- 17.2. Contact Us
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
